IBLClass I
Microscope, Inverted Stage, Tissue Culture
21 CFR 864.3600 / Pathology
IBL is the FDA product code for Microscope, Inverted Stage, Tissue Culture, a class I device type, regulated under 21 CFR 864.3600. As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- IBL
- Device name
- Microscope, Inverted Stage, Tissue Culture
- Regulation
- 21 CFR 864.3600
- Device class
- Class I
- Review panel
- Pathology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- Yes
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this code- Carl Zeiss Microscopy, LLC
- Carl Zeiss Suzhou Co., Ltd.
- CITOTEST Labware Manufacturing CO., Ltd.
- Citotest Scientific Co.,Ltd.
- Evident Corporation
- Evident Nagano Corporation
- Evident Scientific MIS, Inc.
- High Technology, Inc.
- Labotech Microscopes India Private Limited
- Leica Instruments (Shanghai) Co., Ltd.
- Leica Microsystems CMS GmbH
- Motic China Group Co Ltd
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
